Randomized Control Trials (RTC) are a critical method used to identify the treatment effect of heterogeneity.
This process is becoming easier and more effective by utilizing machine learning to isolate subjects who warrant additional study.
In addition, machine learning has become state of the art. It has predictive abilities, thanks to its in-depth data analysis.
Furthermore, RTC can produce false positives. These can make sorting through the data tedious and time-consuming.
Machine learning can be applied to data analysis. This is occurring using a highly advanced algorithm. Machines incorporate helpful data to become more identifiable.
Moreover, this gives researchers a new level of control and customization. These new levels could potentially lead to more robust and transparent research results.
“The growing accessibility and recording of data modalities, arising from genetics, medical imaging, mobile devices, genomics, and electronic health records captured on trial participants, alongside breakthroughs in machine learning (ML) provide new opportunities for scientific discovery of patient strata exhibiting systematic variation in treatment effect.” Watson, J.A., Holmes, C.C stated via the trialsjounral.biomedcentral.com
#ClinicalTrials, #DigitalHealth, #ClinicalData
P.S. Get new Digital Healthcare Article Summaries in your inbox, free. Click here to learn more.